Robotic Duodenopancreatectomy
DOI:
https://doi.org/10.3889/oamjms.2020.3898Keywords:
Robotic duodenopancreatectomy, Pancreaticoduodenectomy, Whipple’s procedure, Morbidity, Mortality, Conversion rate, Hospital stay, Oncological resultsAbstract
INTRODUCTION: Advanced methods of treating pancreatic cancer are being explored to minimize some of the adversities associated with traditional laparoscopy. One of the most promising procedures is robotic duodenopancreatectomy, which appears to reduce morbidity, mortality, conversion rate, hospital stay, and improve oncological results among patients. As such, the procedure is gaining popularity in several medical facilities.
AIM: The article describes robotic duodenopancreatectomy, improved surgical treatment of pancreatic cancer that involves the use of augmented reality.
MATERIALS AND METHODS: The study involves a systematic review of existing literature on robotic duodenopancreatectomy. A total of 16 scholarly articles, published within the past 5 years, are used to synthesize information designed to provide a conclusive summary of evidence related to robotic duodenopancreatectomy. All the materials are retrieved from two medical databases, MEDLINE and ProQuest.
RESULTS/OUTCOME: Morbidity: The rate of morbidity associated with the procedure is relatively high, up to 40%, but slightly lower compared to open laparoscopy, which exhibits morbidity rates of approximately 75%. Mortality: There is evidence of incidences of mortality in robotic duodenopancreatectomy, ranging between 1 and 12.5%. The main cause of death associated with the procedure is post-pancreatic hemorrhage. Conversion rate: The conversion rate in robotic surgery is relatively lower compared to open laparoscopy, ranging between 0 and 37.5%. However, it can decrease to 33.3% after subsequent surgeries. Hospital stay: The procedure is associated with a shorter hospital stays (13.7–24 days) compared to open laparoscopy (25.8 days). Oncological outcomes: Robotic duodenopancreatectomy lacks clear oncological results. However, few studies have established a median overall survival of 15 months.
CONCLUSION: Given that robotic duodenopancreatectomy reduces the rates of mortality, morbidity, conversion rate, and length of hospital stays, it appears to be an ideal treatment of pancreatic cancer.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Kornaropoulos M, Moris D, Beal EW, Makris MC, Mitrousias A, Petrou A, et al. Total robotic pancreaticoduodenectomy: A systematic review of literature. Surg Endosc. 2017;31(11): 4382-92. https://doi.org/10.1007/s00464-017-5523-z PMID: 28389798
Baker E, Ross SW, Martinie JB, Seshadri R, Swan RZ, Iannitti DA, et al. Robotic pancreaticoduodenectomy for pancreatic adenocarcinoma: Role in 2014 and beyond. J Gastrointest Oncol. 2015;6(4):396-405. PMid:26261726
Giulianotti PC, Mangano A, Bianco FM, Bustos RE, Gheza F, Fernandes E, et al. Operative technique in robotic pancreaticoduodenectomy (RPD) at University of Illinois at Chicago (UIC): 17 steps standardized technique: Lessons learned since the first worldwide RPD performed in the year 2001. Surg Endosc. 2018;32(10):4329-36. https://doi. org/10.1007/s00464-018-6228-7 PMid:29766304
Shyr B, Chen S, Wang SE, Shyr YM. Learning curves for robotic pancreatic surgery-from distal pancreatectomy to pancreaticoduodenectomy. Medicine (Baltimore). 2018;97(45):e13000 https://doi.org/10.1097/ md.0000000000013000 PMid:30407289
Montagnini A, Rosok BI, Asbun HJ, Barkun J, Besselink MG, Boggi U, et al. Standardizing terminology for minimally invasive pancreatic resection. HPB (Oxford). 2017;19(3):182-9. PMid:28317657
Lefor AK. Robotic and laparoscopic surgery of the pancreas: An historical review. BMC Biomed Eng. 2019;1(2):6-15.
Joyce D, Morris-Stiff G, Walsh M. Robotic surgery of the pancreas. World J Gastroenterol. 2014;20(40):14726-32. https://doi.org/10.3748/wjg.v20.i40.14726 PMid:25356035
McEvoy SH, Lavelle LP, Hoare SM, O’Neill AC, Awan FN, Malone DE, et al. Pancreaticoduodenectomy: Expected post-operative anatomy and complications. Br J Radiol. 2014;87(1041):20120050. PMid:25026968
Sola RJ, Kirks RC, Iannitti DA, Vronchides D, Martinie JB. Robotic pancreaticoduodenectomy. J Vis Surg. 2016;2:126. https://doi.org/10.21037/jovs.2016.07.06 PMid:29078514
Zimmerman AM, Roye DG, Charpentier KP. A comparison of outcomes between open, laparoscopic and robotic pancreaticoduodenectomy. HPB (Oxford). 2018;20(4):364-9. https://doi.org/10.1016/j.hpb.2017.10.008 PMid:29183703
Aziz H, Shahjehan F, Jie T, Maegawa FB, Zeeshan M, Riall T. Analysis of outcomes of open robotic and laparoscopic pancreaticoduodenectomy using NSQIP. J Pancreas. 2018;19(6):291-5.
Wecowski J, Ross S, Sucandy I, Rosemurgy A. Robotic pancreaticoduodenctomy: A safe minimally invase option. Surgery. 2018;164:1162-7. https://doi.org/10.21037/ ls.2019.02.02
Boone B, Zenati M, Hogg ME, Steve J, Moser AJ, Bartlett DL, et al. Assessment of quality outcomes for robotic pancreaticoduodenectomy: Identification of the learning curve. JAMA Surg. 2015;150(5):416-22.
Nahm CB, Connor SJ, Samra JS, Mittal A. Postoperative pancraetic fistula: A review of traditional and emerging concepts. Clin Exp Gastroenterol. 2018;11(1):105-18. https:// doi.org/10.2147/ceg.s120217 PMid:29588609
Magge D, Zenati M, Lutfi W, Hamad A, Zureikat AH, Zeh HJ, et al. Robotic pacreatoduodenectomy at an experienced institution is not associated with an increased risk of post-pancreatic hemorrhage. HPB (Oxford). 2018;20(5):448-55. https://doi.org/10.1016/j.hpb.2017.11.005 PMid:29366816
Tanaka K, Rangelova E, Chiaro MD. Is robotic pancreatectomy indicated for patients with pancreatic cancer? Ann Pancreat Cancer. 2018;1(5):16. https://doi.org/10.21037/apc.2018.04.01
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2020 Danilo Coco, Silvana Leanza (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
